Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Apirachol
2. Binazin
3. Binazine
4. Ecarazine
5. Todrazoline
1. 14679-73-3
2. Todralacina
3. Todralazina
4. Ecarazine
5. Carboethoxyphthalazinohydrazine
6. Ethyl 3-(1-phthalazinyl)carbazate
7. Bt 621
8. Carbazic Acid, 3-(1-phthalazinyl)-, Ethyl Ester
9. 3-(1-phthalazinyl)carbazic Acid Ethyl Ester
10. Hydrazinecarboxylic Acid, 2-(1-phthalazinyl)-, Ethyl Ester
11. Wen3k83ykd
12. Ceph [as Hydrochloride]
13. Binazin
14. Bt 621 [as Hydrochloride]
15. Nsc-757868
16. Todralacina [spanish]
17. Todralazinum
18. Todralazine [inn:ban]
19. Todralazinum [inn-latin]
20. Todralazina [inn-spanish]
21. Ncgc00016640-03
22. Unii-wen3k83ykd
23. Cas-3778-76-5
24. N-carboethoxy-n'-phthalazino-hydrazine
25. Brn 0233300
26. Todralazine (ban)
27. Ceph
28. Binazine (salt/mix)
29. Ethyl N-(phthalazin-1-ylamino)carbamate
30. Ecarazine (salt/mix)
31. Ceph Free Base
32. Spectrum_001187
33. Todrazoline (salt/mix)
34. Todralazine [mi]
35. Prestwick0_000071
36. Prestwick1_000071
37. Prestwick2_000071
38. Prestwick3_000071
39. Spectrum2_001147
40. Spectrum3_000932
41. Spectrum4_001031
42. Spectrum5_001223
43. Todralazine [inn]
44. Bt-621 Free Base
45. Schembl49644
46. Bspbio_000281
47. Kbiogr_001581
48. Kbioss_001667
49. Todralazine [who-dd]
50. 5-25-17-00414 (beilstein Handbook Reference)
51. Divk1c_000506
52. Spbio_001073
53. Spbio_002202
54. Bpbio1_000311
55. Chembl1079787
56. Dtxsid0045048
57. Chebi:94706
58. Kbio1_000506
59. Kbio2_001667
60. Kbio2_004235
61. Kbio2_006803
62. Kbio3_001964
63. Ninds_000506
64. Hy-b1001
65. Zinc18055768
66. Cs-4498
67. Nsc 757868
68. Idi1_000506
69. Ncgc00016640-01
70. Ncgc00016640-02
71. 1-(n'-ethoxycarbonylhydrazino)phthalazine
72. Da-10133
73. Sbi-0051674.p002
74. Ab00053609
75. Ft-0737585
76. D08613
77. Ethyl 2-(1-phthalazinyl)hydrazinecarboxylate #
78. Ab00053609_08
79. N-(1-phthalazinylamino)carbamic Acid Ethyl Ester
80. Cu-00000000398-1
81. Brd-k68553471-003-04-0
82. Brd-k68553471-003-07-3
83. Q27166508
| Molecular Weight | 232.24 g/mol |
|---|---|
| Molecular Formula | C11H12N4O2 |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 232.09602564 g/mol |
| Monoisotopic Mass | 232.09602564 g/mol |
| Topological Polar Surface Area | 76.1 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 262 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
ABOUT THIS PAGE
82
PharmaCompass offers a list of Todralazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Todralazine manufacturer or Todralazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Todralazine manufacturer or Todralazine supplier.
PharmaCompass also assists you with knowing the Todralazine API Price utilized in the formulation of products. Todralazine API Price is not always fixed or binding as the Todralazine Price is obtained through a variety of data sources. The Todralazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Todralazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Todralazine, including repackagers and relabelers. The FDA regulates Todralazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Todralazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Todralazine supplier is an individual or a company that provides Todralazine active pharmaceutical ingredient (API) or Todralazine finished formulations upon request. The Todralazine suppliers may include Todralazine API manufacturers, exporters, distributors and traders.
Todralazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Todralazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Todralazine GMP manufacturer or Todralazine GMP API supplier for your needs.
A Todralazine CoA (Certificate of Analysis) is a formal document that attests to Todralazine's compliance with Todralazine specifications and serves as a tool for batch-level quality control.
Todralazine CoA mostly includes findings from lab analyses of a specific batch. For each Todralazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Todralazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Todralazine EP), Todralazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Todralazine USP).
